Never Run Out Of Buyers To Sell To.

AmCad BioMed Corporation, established in 2008, is a leader in the field of ultrasound AI diagnostic assessments for various clinical indications. The company was the first to receive an FDA license for ultrasound CAD solution, and has been publicly traded on the Taiwan Stock Exchange since 2015. Its products and pipeline feature the FDA cleared, CE marked and clinically validated soultions including (1) AmCAD-UT for thyroid nodules analysis,(2) AmCAD-UO for obstructive sleep apnea (OSA) detection,(3) AmCAD-US for backscattered signals analysis useful in Liver Steatosis and other diagnosis…

Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Estimated OwnershipPublicMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.